Alendronate is an effective way of increasing BMD and reducing bone turnover
The safety and efficacy of early-stage bi-weekly alendronate to improve bone mineral density and bone turnover in chinese post-menopausal women at risk of osteoporosisJ Int Med Res. 2011;39(1):302-10
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
180 post-menopausal Chinese women, between 40 and 70 years of age, with osteopenia (T-score between -1.6 and -2.4), were randomized into 1 of 2 groups to study the effects of early antiresorptive drug intervention on osteopenia. The first group, classified as the treatment group, was given received 70 mg of alendronate once every 2 weeks plus 0.5 micrograms of alfacalcidol daily, while the second ...
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.Continue